Invasive pneumococcal disease - Annual Epidemiological Report 2016 [2014 data]
In 2014, 17 528 confirmed cases of invasive pneumococcal disease were reported to TESSy.
Invasive pneumococcal disease - Annual Epidemiological Report 2015
In 2015, 21 118 confirmed cases of invasive pneumococcal disease (IPD) were reported to TESSy.
Invasive bacterial diseases - Annual Epidemiological Report 2014 [2012 data]
This report presents the epidemiological situation for vaccine-preventable diseases – invasive bacterial diseases (invasive Haemophilus influenzae, meningococcal and pneumococcal disease) as of 2012 and describes the statistical and epidemiological methods used.
Surveillance of invasive bacterial diseases in Europe, 2012
This report describes the occurrence of invasive bacterial diseases (IBD) in Europe during 2012, based on data collected through The European Surveillance System (TESSy).
External quality assessment scheme for Streptococcus pneumoniae – 2014
In July 2014, a panel of three strains of Streptococcus pneumoniae and two simulated samples of cerebrospinal fluid was sent to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
Invasive pneumococcal disease - Annual Epidemiological Report for 2016
In 2016, 21 986 confirmed cases of invasive pneumococcal disease (IPD) were reported in the EU/EEA.
Generic protocol on enhanced surveillance for invasive pneumococcal disease at the EU/EEA level
The current generic protocol proposes a uniform approach for active invasive pneumococcal disease (IPD) surveillance in children and enhanced surveillance in other age groups.
Surveillance of invasive pneumococcal disease in Europe, 2010
In 2010, a new enhanced surveillance system for invasive pneumococcal disease was established in the European Union, coordinated by ECDC, and this report describes the results of the first year of data collection (2010 data). The main aim is to provide information on the epidemiological trends and morbidity caused by the circulating S. pneumoniae serotypes, antimicrobial susceptibility and certain other epidemiological features of invasive pneumococcal disease.